Deciphering the epidemic synergy of herpes simplex virus type 2 (HSV-2) on human immunodeficiency virus type 1 (HIV-1) infection among women in sub-Saharan Africa
Tóm tắt
Từ khóa
Tài liệu tham khảo
Looker KJ, Garnett GP, Schmid GP: An estimate of the global prevalence and incidence of herpes simplex virus type 2 infection. Bull World Health Organ. 2008, 86 (10): 805-812. 10.2471/BLT.07.046128. A.
Gwanzura L, McFarland W, Alexander D, Burke RL, Katzenstein D: Association between human immunodeficiency virus and herpes simplex virus type 2 seropositivity among male factory workers in Zimbabwe. J Infect Dis. 1998, 177 (2): 481-484. 10.1086/517381.
Reynolds SJ, Risbud AR, Shepherd ME, Zenilman JM, Brookmeyer RS, Paranjape RS, Divekar AD, Gangakhedkar RR, Ghate MV, Bollinger RC, et al: Recent herpes simplex virus type 2 infection and the risk of human immunodeficiency virus type 1 acquisition in India. J Infect Dis. 2003, 187 (10): 1513-1521. 10.1086/368357.
Todd J, Grosskurth H, Changalucha J, Obasi A, Mosha F, Balira R, Orroth K, Hugonnet S, Pujades M, Ross D, et al: Risk factors influencing HIV infection incidence in a rural African population: a nested case–control study. J Infect Dis. 2006, 193 (3): 458-466. 10.1086/499313.
Glynn JR, Biraro S, Weiss HA: Herpes simplex virus type 2: a key role in HIV incidence. AIDS. 2009, 23 (12): 1595-1598. 10.1097/QAD.0b013e32832e15e8.
Mbopi Keou FX, Gresenguet G, Mayaud P, Weiss HA, Gopal R, Brown DW, Hayes RJ, Mabey DC, Belec L: Genital herpes simplex virus type 2 shedding is increased in HIV-infected women in Africa. AIDS (London, England). 1999, 13 (4)): 536-537.
Schacker T, Zeh J, Hu H, Shaughnessy M, Corey L: Changes in plasma human immunodeficiency virus type 1 RNA associated with herpes simplex virus reactivation and suppression. J Infect Dis. 2002, 186 (12): 1718-1725. 10.1086/345771.
Corey L, Wald A, Celum CL, Quinn TC: The effects of herpes simplex virus-2 on HIV-1 acquisition and transmission: a review of two overlapping epidemics. J Acquir Immune Defic Syndr. 2004, 35 (5): 435-445. 10.1097/00126334-200404150-00001.
Johnson RE, Nahmias AJ, Magder LS, Lee FK, Brooks CA, Snowden CB: A seroepidemiologic survey of the prevalence of herpes simplex virus type 2 infection in the United States. N Engl J Med. 1989, 321 (1): 7-12. 10.1056/NEJM198907063210102.
Seroprevalence of herpes simplex virus type 2 among persons aged 14–49 years--United States. MMWR Morb Mortal Wkly Rep. 2005–2008, 59 (15): 456-459.
Abu-Raddad LJ, Magaret AS, Celum C, Wald A, Longini IM, Self SG, Corey L: Genital herpes has played a more important role than any other sexually transmitted infection in driving HIV prevalence in Africa. PLoS One. 2008, 3 (5): e2230-10.1371/journal.pone.0002230.
Celum C, Levine R, Weaver M, Wald A: Genital herpes and human immunodeficiency virus: double trouble. Bull World Health Organ. 2004, 82 (6): 447-453.
Wald A, Corey L: How does herpes simplex virus type 2 influence human immunodeficiency virus infection and pathogenesis?. J Infect Dis. 2003, 187 (10): 1509-1512. 10.1086/374976.
Celum C, Wald A, Lingappa JR, Magaret AS, Wang RS, Mugo N, Mujugira A, Baeten JM, Mullins JI, Hughes JP, et al: Acyclovir and transmission of HIV-1 from persons infected with HIV-1 and HSV-2. N Engl J Med. 2010, 362 (5): 427-439. 10.1056/NEJMoa0904849.
Wawer MJ, Gray RH, Sewankambo NK, Serwadda D, Li X, Laeyendecker O, Kiwanuka N, Kigozi G, Kiddugavu M, Lutalo T, et al: Rates of HIV-1 transmission per coital act, by stage of HIV-1 infection, in Rakai, Uganda. J Infect Dis. 2005, 191 (9): 1403-1409. 10.1086/429411.
Mbopi-Keou FX, Legoff J, Gresenguet G, Si-Mohamed A, Matta M, Mayaud P, Andreoletti L, Malkin JE, Weiss H, Brown D, et al: Genital shedding of herpes simplex virus-2 DNA and HIV-1 RNA and proviral DNA in HIV-1- and herpes simplex virus-2-coinfected African women. J Acquir Immune Defic Syndr. 2003, 33 (2): 121-124. 10.1097/00126334-200306010-00001.
Ouedraogo A, Nagot N, Vergne L, Konate I, Weiss HA, Defer MC, Foulongne V, Sanon A, Andonaba JB, Segondy M, et al: Impact of suppressive herpes therapy on genital HIV-1 RNA among women taking antiretroviral therapy: a randomized controlled trial. AIDS. 2006, 20 (18): 2305-2313. 10.1097/QAD.0b013e328010238d.
Zuckerman RA, Lucchetti A, Whittington WL, Sanchez J, Coombs RW, Zuniga R, Magaret AS, Wald A, Corey L, Celum C: Herpes simplex virus (HSV) suppression with valacyclovir reduces rectal and blood plasma HIV-1 levels in HIV-1/HSV-2-seropositive men: a randomized, double-blind, placebo-controlled crossover trial. J Infect Dis. 2007, 196 (10): 1500-1508. 10.1086/522523.
Tanton C, Weiss HA, Rusizoka M, Legoff J, Changalucha J, Baisley K, Mugeye K, Everett D, Belec L, Clayton TC, et al: Long-term impact of acyclovir suppressive therapy on genital and plasma HIV RNA in Tanzanian women: a randomized controlled trial. J Infect Dis. 2010, 201 (9): 1285-1297. 10.1086/651696.
Ludema C, Cole SR, Poole C, Chu H, Eron JJ: Meta-analysis of randomized trials on the association of prophylactic acyclovir and HIV-1 viral load in individuals coinfected with herpes simplex virus-2. AIDS. 2011, 25 (10): 1265-1269. 10.1097/QAD.0b013e328347fa37.
Lisco A, Vanpouille C, Tchesnokov EP, Grivel JC, Biancotto A, Brichacek B, Elliott J, Fromentin E, Shattock R, Anton P, et al: Acyclovir is activated into a HIV-1 reverse transcriptase inhibitor in herpesvirus-infected human tissues. Cell Host Microbe. 2008, 4 (3): 260-270. 10.1016/j.chom.2008.07.008.
Lisco A, Vanpouille C, Margolis L: A missed point in deciphering the viral synergy between herpes simplex virus and HIV. Lancet Infect Dis. 2009, 9 (9): 522-523. 10.1016/S1473-3099(09)70209-9.
Nilsen A, Mwakagile D, Marsden H, Langeland N, Matre R, Haarr L: Prevalence of, and risk factors for, HSV-2 antibodies in sexually transmitted disease patients, healthy pregnant females, blood donors and medical students in Tanzania and Norway. Epidemiol Infect. 2005, 133 (5): 915-925. 10.1017/S095026880500395X.
Ghebremichael M, Larsen U, Paintsil E: Association of age at first sex with HIV-1, HSV-2, and other sexual transmitted infections among women in northern Tanzania. Sex Transm Dis. 2009, 36 (9): 570-576. 10.1097/OLQ.0b013e3181a866b8.
Rabe-Hesketh S, Skrondal A: Classical latent variable models for medical research. Stat Methods Med Res. 2008, 17 (1): 5-32.
Schabenberger O: Growing up fast: SAS 9.2 enhancements to the GLIMMIX procedure. 2007, Orlando, FL: SAS Global Forum
Wald A, Link K: Risk of human immunodeficiency virus infection in herpes simplex virus type 2-seropositive persons: a meta-analysis. J Infect Dis. 2002, 185 (1): 45-52. 10.1086/338231.
Freeman EE, Weiss HA, Glynn JR, Cross PL, Whitworth JA, Hayes RJ: Herpes simplex virus 2 infection increases HIV acquisition in men and women: systematic review and meta-analysis of longitudinal studies. AIDS. 2006, 20 (1): 73-83. 10.1097/01.aids.0000198081.09337.a7.
Brown JM, Wald A, Hubbard A, Rungruengthanakit K, Chipato T, Rugpao S, Mmiro F, Celentano DD, Salata RS, Morrison CS, et al: Incident and prevalent herpes simplex virus type 2 infection increases risk of HIV acquisition among women in Uganda and Zimbabwe. AIDS. 2007, 21 (12): 1515-1523. 10.1097/QAD.0b013e3282004929.
del Mar Pujades Rodriguez M, Obasi A, Mosha F, Todd J, Brown D, Changalucha J, Mabey D, Ross D, Grosskurth H, Hayes R: Herpes simplex virus type 2 infection increases HIV incidence: a prospective study in rural Tanzania. AIDS. 2002, 16 (3): 451-462. 10.1097/00002030-200202150-00018.
Kapiga SH, Bang H, Spiegelman D, Msamanga GI, Coley J, Hunter DJ, Fawzi WW: Correlates of plasma HIV-1 RNA viral load among HIV-1-seropositive women in Dar es Salaam, Tanzania. J Acquir Immune Defic Syndr. 2002, 30 (3): 316-323.
Cunningham AL, Turner RR, Miller AC, Para MF, Merigan TC: Evolution of recurrent herpes simplex lesions, An immunohistologic study. J Clin Invest. 1985, 75 (1): 226-233. 10.1172/JCI111678.
Koelle DM, Abbo H, Peck A, Ziegweid K, Corey L: Direct recovery of herpes simplex virus (HSV)-specific T lymphocyte clones from recurrent genital HSV-2 lesions. J Infect Dis. 1994, 169 (5): 956-961. 10.1093/infdis/169.5.956.
Margolis DM, Rabson AB, Straus SE, Ostrove JM: Transactivation of the HIV-1 LTR by HSV-1 immediate-early genes. Virology. 1992, 186 (2): 788-791. 10.1016/0042-6822(92)90048-T.